Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 18 Similar Profiles
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Mutation Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2019

Oncogenes
Neoplasms
Therapeutics
anaplastic lymphoma kinase
Phosphotransferases

Research Output 2006 2017

  • 737 Citations
  • 11 h-Index
  • 21 Article
  • 1 Comment/debate

A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma

Puvvada, S. D., Guillén-Rodríguez, J. M., Rivera, X. I., Heard, K., Inclan, L., Schmelz, M., Schatz, J. H. & Persky, D. O. Sep 5 2017 (Accepted/In press) In : Oncology (Switzerland).

Research output: Research - peer-reviewArticle

Lymphoma
ibritumomab tiuxetan
belinostat
Lymphoma, Large B-Cell, Diffuse
Major Histocompatibility Complex

ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A

Tillotson, J., Kedzior, M., Guimarães, L., Ross, A. B., Peters, T. L., Ambrose, A. J., Schmidlin, C. J., Zhang, D. D., Costa-Lotufo, L. V., Rodríguez, A. D., Schatz, J. H. & Chapman, E. 2017 In : Bioorganic and Medicinal Chemistry Letters. 27, 17, p. 4082-4085 4 p.

Research output: Research - peer-reviewArticle

Biological Products
Adenosine Triphosphatases
Adenosine Triphosphate
Neoplasms
Cells

Double hit lymphoma presenting as haemophagocytic lymphohistiocytosis

Rivera, X. I., McGhan, L. J., Schatz, J. H. & Puvvada, S. D. 2017 In : BMJ Case Reports. 2017, 220401

Research output: Research - peer-reviewComment/debate

Phase 2 Open-Label Study of Bortezomib, Cladribine, and Rituximab in Advanced, Newly Diagnosed, and Relapsed/Refractory Mantle-Cell and Indolent Lymphomas

Puvvada, S. D., Guillen-Rodriguez, J., Kumar, A., Inclán, L., Heard, K., Rivera, X. I., Anwer, F., Schatz, J. H., Mahadevan, D. & Persky, D. O. 2017 (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Research - peer-reviewArticle

Cladribine
Mantle-Cell Lymphoma
Bortezomib
Rituximab
Non-Hodgkin's Lymphoma
1 Citations

Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447

Peters, T. L., Li, L., Tula-Sanchez, A. A., Pongtornpipat, P. & Schatz, J. H. 2016 In : Oncotarget. 7, 39, p. 63362-63373 12 p.

Research output: Research - peer-reviewArticle

Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
Phosphotransferases
Neoplasms
Inhibition (Psychology)